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To better understand the function of p53 in carcinogenesis, this study tried to isolate the novel 
downstream targets of p53 by differential expression profiles. Elegant experiments were performed to 
prove the late cornified envelope group I (LCE1) as new p53 target with function of importance. 
 
First, the microarray analysis suggested that the expression levels of LCE1B and LCE1C, two 
members of LCE1 family, were induced over seven folds by the exogenous introduction of wild-type p53 
in U373MG cells (p53 mutated). By quantitative RT-PCR (qPCR), further investigation showed that 
besides LCE1B, LCE1C,other LCE members such as LCE1E and LCE1F were also up-regulated by the 
exogenous p53 in U373MG and H1299 (p53 null) cells. Furthermore, DNA damage such as Adriamycin 
or UV irradiation strongly induced the expression of LCE1A, LCE1B, LCE1C, LCE1E and LCE1F in a 
p53 dependent manner. Meanwhile, siRNA of p53 significantly abolished the induction of these genes by 
DNA damage. It strongly suggested LCE1B, LCE1C, LCE1E and LCE1F as p53 target genes.  
 
Then, at least three regions containing p53-binding motifs (p53BS2, p53BS6, and p53BS7) were 
identified with enhancer activity in wide type p53 dependent manner by reporter assay. Specially, p53BS2 
in the 5’ flanking region of LCE1F may associate directly with p53 by chromatin immunoprecipitation 
(ChIP) assay. In addition, LCE1F expression was found much lower in p53 mutant cells compared with 
p53 wild-type cells by qPCR. Clearly, at least LCE1F is a direct target gene of p53.  
 
To search for the interacting protein(s) of LCE1 proteins, HA-tagged LCE1A-F proteins expressed in 
HEK293T cells were pulled down by HA. Then immunoprecipitants were excised and analyzed by liquid 
chromatography-tandem mass spectrometry (LC-MS/MS). Protein arginine methyltransferase 5 (PRMT5) 
was found to be one of the best candidates. Subsequent co-immunoprecipitation assay validated the 
interaction of ectopic LCE1F with both exogenous and endogenous PRMT5. PRMT5 was further shown 
to co-localize with LCE1F in both the cytoplasm and the nucleus by immunocytochemical analysis.  
 
PRMT5 is one of the best-characterized PRMTs with symmetric di-methyl arginine (sDMA) activity. 
An important key marker of the PRMT5 activity is the level of symmetric di-methylated histone 3 
arginine 8 (H3R8me2s). Through hypermethylation of histone H3R8, PRMT5 could directly silence the 
tumor suppressor genes such as Retinoblastoma (RB) family proteins by transcription.  
 
Gain of function and loss of function experiments were performed to figure out the role of interaction 
between LCE1F and PRMT5. The suppression of LCE1 or p53 by siRNAs remarkably increased the 
methylation level of H3R8me2s specific to PMRT5, while the ectopic LCE1F dramatically decreased the 
methylation level of H3R8me2s. If this is true, LCE1 will be of great interests as the negative regulator of 
PRMT5, which is considered as onco-protein with overexpression in various types of human cancer. 
 
In conclusion, here the authors have demonstrated that LCE1 family members of LCE1A, LCE1B, 
LCE1C, LCE1E and LCE1F are novel p53 downstream genes, and that at least LCE1F, one of the 
members, is a direct target gene transactivated by p53. Interestingly, LCE1 was found to negatively 
regulate histone H3 methylation through the interaction with PRMT5.  
 
LCE1 genes are expressed mainly in the outermost layer of the epidermis, suggesting the essential 
role in maintenance of barrier function. Physiological function of LCE proteins remains largely unknown. 
Definitely, this study provides us new function of LCE1 as p53 targets, especially its involvement in 
human cancer for the first time. Future investigations for the will pave the road to reveal the detailed 
mechanisms of p53 in carcinogenesis. Thus, it deserves to the PhD degree from the University of Tokyo. 
